Sponsor pipeline

Novatim Immune Therapeutics (Zhejiang) Co., Ltd. clinical trial pipeline

Get alerts when Novatim Immune Therapeutics (Zhejiang) Co., Ltd.'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

Active trials by phase

Phase 1
1
Phase 1/2
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 1/2
NCT06928363 A First-in-human Study of KY-0301 in Patients With Advanced Solid Tumors. Solid Tumors Not Yet Recruiting 2025-04-15
Phase 1
NCT06518876 A Study of KQ-2003 CAR-T Cell Therapy for Patients With Relapsed or Refractory POEMS… POEMS Syndrome Not Yet Recruiting 2024-07-24
Get alerts when Novatim Immune Therapeutics (Zhejiang) Co., Ltd.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free